Why this MTG format exploded in popularity almost 15 years after it was invented
What if you didn’t have to keep up with Magic: The Gathering’s relentless release schedule? What if power…
Novo Nordisk’s Pill Strategy Gets a Double Boost – EU Nod and Analyst Upgrade – Yet the Growth S
Novo Nordisk shares have recouped more than 40% from their early-March low, but the stock still sits nearly…
New MTG Stardew Valley and Hatsune Miku Secret Lairs revealed, with 79 cards total!
A grand total of 79 Magic: The Gathering Secret Lair cards were revealed at MagicCon Amsterdam today, with…
Novo Nordisk’s Twin-Track Strategy: Price Cuts and Pill Power
Novo Nordisk is pressing on multiple fronts at once, slashing US list prices for its blockbuster obesity and…
Novo Nordisk’s Combination Strategy Takes Center Stage as Pipeline Advances, Shares Stay Muted
Novo Nordisk shares drop 4.57%, 47% off high, yet pipeline progress includes Veru collaboration on Wegovy combo, ADA…
Novo Nordisk Streamlines Operations as Oral Wegovy Data Reinforce Obesity Strategy
Novo Nordisk sells Parkinson’s candidate to focus on metabolic drugs; oral Wegovy shows 21.6% weight loss at 64…
A$24 Million Shortfall Threatens European Lithium’s Greenland Exit Strategy
European Lithium faces a $24M cash gap ahead of a binding merger deadline with Critical Metals Corp., risking…
European Lithium’s Dual-Pronged Strategy Gains Momentum with Greenland Milestone
European Lithium sees major gains from its stake in Critical Metals’ Tanbreez project, strengthening its balance sheet and…
BYD’s Beijing Reveal and Brussels Bid Signal a Two-Speed Global Strategy
BYD unveils a redesigned Atto 3 EV with 5-minute fast charge to counter a 73% sales drop in…
Novo Nordisk’s Pill Price War Intensifies as AI Strategy Unfolds
Novo Nordisk slashes prices and partners with OpenAI as its oral weight-loss drug faces fierce competition from Eli…
Novo Nordisk’s Triple-Thrust Strategy to Revive a Slumping Stock
Novo Nordisk launches Wegovy HD injection and oral pill to combat Eli Lilly, gains EU storage advantage, and…
Novo Nordisk’s Pill and Needle Strategy Faces a Competitive and Financial Crossroads
Novo Nordisk launches high-dose & oral Wegovy in the US and eases EU cold-chain rules to compete with…